Darrin Kiessling

Background

About Darrin Kiessling

Extensive experience in marketing strategy, customer insights, product launches, and developing and executing complex, omnichannel messaging and recruitment campaigns for consumer and HCP audiences: – Mature brands – BMS: OPDIVO + YERVOY for 1L/neoadjuvant NSCLC; and OPDIVO for bladder cancer; Cephalon/Teva: PROVIGIL for various sleep disorders; ACTIQ for breakthrough cancer pain – Brand/product launch – Cephalon/Teva: NUVIGIL for various sleep disorders; FENTORA for breakthrough cancer pain; TREANDA for CLL, NHL, AML; OMAPRO for CML – Investigational products – GSK: TRELEGY ELLIPTA for asthma/COPD; VALTREX for herpes/shingles; Pfizer/BioNTech and Moderna COVID-19 vaccines; and many others… Launch and operational excellence champion: MLR prioritization and management of promotional materials in Veeva, from initial creative brief, to development, review, approval, 2253 submission, flighting, and beyond. Close internal cross-functional organizational collaboration and partnership with external AOR and creative agencies to align promotional campaigns to key Brand strategy/positioning. Execution of omnichannel tactics for consumers and HCPs, go-to-market strategy and tactics, personal and non-personal promotional collateral, and educational and commercial training materials. A wartime campaign veteran and training specialist honored for distinguished military service, which included tours of duty at Fort Liberty, NC, Southwest Asia, and Germany. Specialties: Writing and editing, technical writing, medical writing, editing, technical editing, graphic design, medical communications, oncology (including hematologic cancers), narcolepsy, obstructive sleep apnea, opioids, major step depressive disorder, bipolar depression, pain, pain medicine, pharmaceutical industry, PowerPoint, publications, publishing, leukemia, lymphoma, solid tumors, shiftwork sleep disorder, sleep/wake medicine